首页> 外文OA文献 >Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

【2h】

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

机译：Sentinel节点活检的时序独立地预测临床I-II黑色素瘤患者的无病和整体生存率：意大利黑素瘤杂交族的多期几项研究（IMI）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Mario Mandalà; Francesca Galli; Roberto Patuzzo; Andrea Maurichi; Simone Mocellin; Carlo R. Rossi; Eliana Rulli; Maria Montesco; Pietro Quaglino; Virginia Caliendo; Vincenzo De Giorgi; Barbara Merelli; Corrado Caracò; Dario Piazzalunga; Alice Labianca; Simone Ribero; Rebecca Senetta; Andrea Gianatti; Barbara Valeri; Daniela Massi; Paolo A. Ascierto; Mario Santinami;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study [J] . Carlo Riccardo Rossi, Simone Mocellin, Luca Giovanni Campana, Annals of surgical oncology . 2018 ,第1期

机译：黑色素瘤患者非哨兵节点状态的预测和正哨节点活组织检查：意大利黑色素瘤族群（IMI）研究
2. Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study [J] . Carlo Riccardo Rossi, Simone Mocellin, Luca Giovanni Campana, Annals of surgical oncology . 2018 ,第1期

机译：黑色素瘤患者非哨兵节点状态的预测和正哨节点活组织检查：意大利黑色素瘤族群（IMI）研究
3. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. [J] . Mandala M, Imberti GL, Piazzalunga D European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2009 ,第14期

机译：临床和组织病理学危险因素预测临床阶段I-II AJCC Skanoma的临床阶段淋巴结积极性，无病和整体存活的临床和整体生存率：从单机构前瞻性收集数据库的结果分析。
4. PROTEOMIC PROFILING OF MELANOMA CELL LINES AND TISSUE USING DATA INDEPENDENT ACQUISITION MASS SPECTROMETRY TO PREDICT TREATMENT RESPONSE AND PATIENT SURVIVAL [C] . Christoph Krisp, Robert Parker, Dana Pascovici, International Mass Spectrometry Conference . 2018

机译：黑色素瘤细胞系和组织的蛋白质组学分析使用数据无关的采集质谱来预测治疗反应和患者存活
5. Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) [O] . Irene Vanni, Milena Casula, Lorenza Pastorino, 2020

机译：意大利黑色素瘤中临床下一代测序黑色素瘤面板的质量评估（IMI）
6. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group study [O] . Ophuis, C. M. C. Oude, Verhoef, C., Rutkowski, P., 2016

机译：EORTC黑色素瘤小组研究表明，原发黑色素瘤切除与前哨淋巴结活检之间的间隔与前哨淋巴结阳性患者的生存率无关

Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)

著录项

相似文献

相关主题

期刊订阅